Whole Cell Cholera Vaccine Report Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021-2026

Report Code: HCR 10855 Report Format: PDF + Excel (Delivery in 48 Hrs)

Whole Cell Cholera Vaccine Market Overview

Whole Cell Cholera Vaccine Market size is estimated to reach $5,000 million by 2026, growing at a CAGR of 9.8% over 2021-2026 forecast period. Whole cell cholera vaccine is used for the prevention of cholera disease. Recombinant B-subunit has combination with killed whole cell V. Cholera O1 that provide more protection and increases immunization. Cholera is a kind of diarrheal disease which is caused by the ingestion of food or water contaminated with the bacterium vibrio cholera. Cholera Vaccine such as Dukoral is formulated with killed V. cholerae O1 together with the recombinant cholera toxin B subunit helps to increase immunity to fight for cholera disease. Growing incidence of cholera and rising demand for vaccine is the major factor driving the growth of this market. Furthermore, increasing research and development activities is set to further enhance the overall market demand for Whole Cell Cholera Vaccine Market for the period 2021-2026.

Report Coverage

The report: “Whole Cell Cholera Vaccine Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Whole Cell Cholera Vaccine Market.   
By Type: Adult, and Children
By End-Use Industry: Hospitals, Clinical Research Institutes, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa)

Key Takeaways

  • Geographically, in 2020, Asia Pacific dominated the Whole Cell Cholera Vaccine Market owing to increasing cholera disease and rising developments in research institutes for vaccine.
  • Growing incidence of cholera and rising demand for vaccine are likely to aid in the market growth of the Whole Cell Cholera Vaccine. 
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Whole Cell Cholera Vaccine Market report. 
  • High cost and time required to produce vaccine is set to create hurdles for the Whole Cell Cholera Vaccine Market.

Whole Cell Cholera Vaccine Market Size, By End-Use Industry
2020-2026 (USD Million)



For more details on this report - Request for Sample

Whole Cell Cholera Vaccine Segment Analysis – By Type

The global Whole Cell Cholera Vaccine Market based on Type can be further segmented into Adults, and Children. The Adults segment is the major segment generating revenue in 2020. This is owing to rising cases of cholera diseases among adults and increasing sanitization and hygiene issue among adults. The Children segment is estimated to register the fastest CAGR of 4.2% for the period 2021-2026. This is owing to increasing doses of cholera vaccine among children owing to increasing bacterium vibrio cholerae that increases the demand of whole cell cholera vaccine and are increasing the growth of this segment. 

Whole Cell Cholera Vaccine Segment Analysis – By End-Use Industry

The global Whole Cell Cholera Vaccine Market based on End-Use Industry can be further segmented into, Hospitals, Clinical Research Institutes, and Others. The Hospitals segment registers for the Whole Cell Cholera Vaccine highest market share in 2020. This is mainly owing to increasing availability of large number of vaccines and provides quick services, availability of skilled professional. Moreover, increasing availability of recombinant B- Subunit to increase immunity against cholera increases the demand of vaccine and are increasing the growth of this segment. The Clinical Research Institutes segment is estimated to register the fastest CAGR of 2.6% over 2021-2026. This is mainly owing to increasing clinical procedure for the approval of vaccine increases the research and are increasing the growth of this market.

Whole Cell Cholera Vaccine Segment Analysis – By Geography

Asia Pacific dominated the Whole Cell Cholera Vaccine Market with major share of 40% in 2020. This is owing to increasing cholera disease and rising developments in research institutes for vaccine. According to World Health Organization, about 67% of people in Asia Pacific are suffering from cholera disease in 2016 that increases the demand of cholera vaccine and are rising the growth of this market.
However, North America is estimated to outpace all the regions by clocking the highest CAGR of 6.8% during the forecast period 2021-2026 owing to rising demand of vaccine and increasing development in healthcare. 

Whole Cell Cholera Vaccine Market Drivers

Growing Incidence of Cholera

Increasing incidence of cholera and increasing demand for cholera O1 vaccine increases the growth of the Whole Cell Cholera Vaccine Market. According to World Health Organization, about 4 million cases of cholera are estimated and about 21000- 143000 deaths occur in 2020 that increasing the growth of the Whole Cell Cholera Vaccine Market over 2021-2026. 

Rising Demand of Vaccine

Increasing demand of vaccine to increases the immunity against cholera is increasing the growth of the Whole Cell Cholera Vaccine Market. According to World Health Organization, in 2017 about 10 million doses of oral cholera vaccine are funded in various countries that increases the growth of Whole Cell Cholera Vaccine Market over 2021-2026.  

Covid-19 Impact: 

COVID-19 pandemic had greatly affected the Whole Cell Cholera Vaccine Market. Owing to pandemic, there is lockdowns that increases the problems in supply chain of vaccine and manufacturer production capacities that increases the risk in the continuation of immunization programmes for cholera vaccine that are negatively affected the growth of this market. 

Whole Cell Cholera Vaccine Market Challenges

High Cost and Time Required

The factors that is set to impede the growth of the Whole Cell Cholera Vaccine Market are the high cost and time required to produce vaccine. Moreover, lack of access to adequate care for cholerais set to create hurdles for the Whole Cell Cholera Vaccine Market. 

Whole Cell Cholera Vaccine Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Whole Cell Cholera Vaccine Market. Whole Cell Cholera Vaccine top 10 companies include, AstraZeneca, Shantha Biotechnics Private Limited, Valneva SE, Merck & Co. Inc., EuBiologics, Sanofi, Emergent Biosolutions Inc., Valneva SE, GlaxoSmith, and Astellas Pharma Inc.

Developments

  • In October 2020, EuBiologics are working on the development of whole cell vaccine and manufactured bivWC vaccine, which is low expensive and increasingly used to prevent cholera.

Relevant Reports:

Report Code: HCR 84690

Report Code: HCR 0591

For more Lifesciences and Healthcare Market reports, please click here
1. Whole Cell Cholera Vaccine Market Overview
    1.1  Definitions and Scope
2. Whole Cell Cholera Vaccine Market Executive Summary
    2.1 Market Size and Key Trends
    2.2 Key trends by Type
    2.3 Key trends by End-Use Industry 
    2.4 Key trends by Geography
3. Whole Cell Cholera Vaccine Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Whole Cell Cholera Vaccine Market- Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Whole Cell Cholera Vaccine Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Whole Cell Cholera Vaccine Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Whole Cell Cholera Vaccine Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8.  Whole Cell Cholera Vaccine Market– By Type (Market Size -$Million/$Billion)
    8.1 Adult
    8.2 Children
9. Whole Cell Cholera Vaccine Market– By End-Use Industry (Market Size -$Million/$Billion)
    9.1 Hospitals
    9.2 Clinical Research Institutes
    9.3 Others
10. Whole Cell Cholera Vaccine Market- By Geography (Market Size -$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 U.K.
        10.2.2 Germany
        10.2.3 Italy
        10.2.4 France
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 Australia
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 India
        10.3.6 Rest of Asia-Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Others
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Whole Cell Cholera Vaccine Market Entropy
12. Whole Cell Cholera Vaccine Market- Industry / Segment Competition landscape Premium Premium
    12.1 Market Share Analysis
        12.1.1 Market Share by Country- Key companies
        12.1.2 Market Share by Region- Key companies
        12.1.3 Market Share at Global Level- Key companies
        12.1.4 Best Practices for Companies
13. Whole Cell Cholera Vaccine Market- Key Company List by Country Premium Premium
14. Whole Cell Cholera Vaccine Market Company Analysis
    14.1 Company Revenue, Products, M&A, Developments
    14.2 Company 1
    14.3 Company 2
    14.4 Company 3
    14.5 Company 4
    14.6 Company 5
    14.7 Company 6
    14.8 Company 7
    14.9 Company 8
    14.10 Company 9
    14.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global GLOBAL WHOLE CELL CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
1.1 PEDIATRICS Market 2019-2024 ($M) - Global Industry Research
1.2 ADULTS Market 2019-2024 ($M) - Global Industry Research
2.Global GLOBAL WHOLE CELL CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 (Volume/Units)
2.1 PEDIATRICS Market 2019-2024 (Volume/Units) - Global Industry Research
2.2 ADULTS Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America GLOBAL WHOLE CELL CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
3.1 PEDIATRICS Market 2019-2024 ($M) - Regional Industry Research
3.2 ADULTS Market 2019-2024 ($M) - Regional Industry Research
4.South America GLOBAL WHOLE CELL CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
4.1 PEDIATRICS Market 2019-2024 ($M) - Regional Industry Research
4.2 ADULTS Market 2019-2024 ($M) - Regional Industry Research
5.Europe GLOBAL WHOLE CELL CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
5.1 PEDIATRICS Market 2019-2024 ($M) - Regional Industry Research
5.2 ADULTS Market 2019-2024 ($M) - Regional Industry Research
6.APAC GLOBAL WHOLE CELL CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
6.1 PEDIATRICS Market 2019-2024 ($M) - Regional Industry Research
6.2 ADULTS Market 2019-2024 ($M) - Regional Industry Research
7.MENA GLOBAL WHOLE CELL CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
7.1 PEDIATRICS Market 2019-2024 ($M) - Regional Industry Research
7.2 ADULTS Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
2.Canada Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
3.Mexico Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
4.Brazil Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
5.Argentina Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
6.Peru Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
7.Colombia Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
8.Chile Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
9.Rest of South America Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
10.UK Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
11.Germany Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
12.France Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
13.Italy Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
14.Spain Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
15.Rest of Europe Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
16.China Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
17.India Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
18.Japan Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
19.South Korea Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
20.South Africa Whole Cell Cholera Vaccine Report Market Revenue, 2019-2024 ($M)
21.North America Whole Cell Cholera Vaccine Report By Application
22.South America Whole Cell Cholera Vaccine Report By Application
23.Europe Whole Cell Cholera Vaccine Report By Application
24.APAC Whole Cell Cholera Vaccine Report By Application
25.MENA Whole Cell Cholera Vaccine Report By Application
26.SBL VACCINE, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.PAXVAX, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.VALNEVA SE, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.GLAXOSMITHKLINE PLC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.JOHNSON JOHNSON, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.MERCK CO., INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.PFIZER INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.SANOFI PASTEUR, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.ASTRAZENECA PLC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.SERUM INSTITUTE OF INDIA PVT. LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)